University of Vermont, Department of Medicine, Colchester, VT 05446, USA.
Thromb Res. 2012 Nov;130(5):716-9. doi: 10.1016/j.thromres.2012.07.012. Epub 2012 Aug 12.
P-selectin is a cell adhesion molecule shown to play a role in venous thromboembolism. We evaluated whether higher P-selectin is associated with chronic venous insufficiency (CVI).
In a cohort of 2408 participants, the San Diego Population Study, peripheral venous disease was established by symptoms, clinical examination, and ultrasound. We measured P-selectin in a subsample of 352 CVI cases frequency matched to controls. Cases included four hierarchical groups of increasing severity of CVI.
The association of P-selectin with CVI considering all cases was weak, with an age, race and sex-adjusted odds ratio (OR) of 1.3 (95% CI 1.0-2.2) for values in the 3rd versus 1st tertile. The OR for cases in the two most severe groups was 2.3 (95% CI 1.2-4.2). Addition of body mass index to the model reduced this OR to 1.9 (95% CI 1.0-3.6).
Higher circulating P-selectin was associated with more severe CVI, but not CVI overall. Results support that platelet and endothelial cell activation may be involved in the pathogenesis of CVI.
P-选择素是一种细胞黏附分子,其在静脉血栓栓塞中发挥作用。我们评估了较高的 P-选择素是否与慢性静脉功能不全(CVI)有关。
在一项由 2408 名参与者组成的队列研究中,圣地亚哥人群研究通过症状、临床检查和超声来确定外周静脉疾病。我们在与对照组频数匹配的 352 例 CVI 病例的亚样本中测量了 P-选择素。病例包括 CVI 严重程度逐渐增加的四个分层组。
考虑到所有病例,P-选择素与 CVI 的相关性较弱,第 3 tertile 与第 1 tertile 相比,年龄、种族和性别调整后的比值比(OR)为 1.3(95% CI 1.0-2.2)。在两个最严重的组中,病例的 OR 为 2.3(95% CI 1.2-4.2)。将体重指数添加到模型中,将该 OR 降低至 1.9(95% CI 1.0-3.6)。
较高的循环 P-选择素与更严重的 CVI 相关,但与 CVI 整体无关。结果支持血小板和内皮细胞激活可能参与 CVI 的发病机制。